*VIVESTO SIGNS DEAL WITH KAZIA THERAPEUTICS TO ACQUIRE FULL CANTRIXIL RIGHTS
*TO ACQUIRE FULL RIGHTS, INCLUDING ALL INTELLECTUAL PROPERTY AND TRADEMARKS RIGHTS FOR DRUG CANDIDATE CANTRIXIL FOR 1 MUSD
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 31-MAR-202506:00:05.88 GMT